Drugs / PUR118
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01690949 | Aug 2012 → Apr 2013 | chronic obstructive pulmonary disease | Pulmatrix Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01543191 | Feb → Dec 2012 | cystic fibrosis | Pulmatrix Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01333904 | Feb 2011 → Jun 2012 | chronic obstructive pulmonary disease | Pulmatrix Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PUR118 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01543191 ↗ |
| Route | Inhaled | “inhaled” NCT01333904 ↗ |